AKSO HEALTH GROUP (AHG) Stock Fundamental Analysis

NASDAQ:AHG • US98422P1084

1.31 USD
-0.11 (-8.07%)
Last: Mar 2, 2026, 08:01 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

Overall AHG gets a fundamental rating of 3 out of 10. We evaluated AHG against 101 industry peers in the Health Care Providers & Services industry. While AHG has a great health rating, there are worries on its profitability. AHG is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • AHG had negative earnings in the past year.
  • AHG had a positive operating cash flow in the past year.
  • AHG had negative earnings in each of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: AHG reported negative operating cash flow in multiple years.
AHG Yearly Net Income VS EBIT VS OCF VS FCFAHG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M -100M

1.2 Ratios

  • AHG has a worse Return On Assets (-62.79%) than 89.11% of its industry peers.
  • AHG's Return On Equity of -67.79% is on the low side compared to the rest of the industry. AHG is outperformed by 74.26% of its industry peers.
Industry RankSector Rank
ROA -62.79%
ROE -67.79%
ROIC N/A
ROA(3y)-25.43%
ROA(5y)-42.59%
ROE(3y)-30.24%
ROE(5y)-85.85%
ROIC(3y)N/A
ROIC(5y)N/A
AHG Yearly ROA, ROE, ROICAHG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150 -200

1.3 Margins

  • AHG does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AHG Yearly Profit, Operating, Gross MarginsAHG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600 -800 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • AHG does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The debt/assets ratio for AHG has been reduced compared to a year ago.
AHG Yearly Shares OutstandingAHG Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M 25M
AHG Yearly Total Debt VS Total AssetsAHG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

2.2 Solvency

  • AHG has an Altman-Z score of 29.39. This indicates that AHG is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 29.39, AHG belongs to the top of the industry, outperforming 99.01% of the companies in the same industry.
  • AHG has a debt to FCF ratio of 1.96. This is a very positive value and a sign of high solvency as it would only need 1.96 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 1.96, AHG is in the better half of the industry, outperforming 79.21% of the companies in the same industry.
  • AHG has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
  • AHG has a better Debt to Equity ratio (0.01) than 84.16% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 1.96
Altman-Z 29.39
ROIC/WACCN/A
WACC7.53%
AHG Yearly LT Debt VS Equity VS FCFAHG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 14.20 indicates that AHG has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 14.20, AHG belongs to the best of the industry, outperforming 99.01% of the companies in the same industry.
  • A Quick Ratio of 14.18 indicates that AHG has no problem at all paying its short term obligations.
  • AHG has a Quick ratio of 14.18. This is amongst the best in the industry. AHG outperforms 99.01% of its industry peers.
Industry RankSector Rank
Current Ratio 14.2
Quick Ratio 14.18
AHG Yearly Current Assets VS Current LiabilitesAHG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • AHG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -146.56%.
  • Looking at the last year, AHG shows a very strong growth in Revenue. The Revenue has grown by 512.09%.
  • The Revenue has been growing by 16.45% on average over the past years. This is quite good.
EPS 1Y (TTM)-146.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-374.64%
Revenue 1Y (TTM)512.09%
Revenue growth 3Y35.05%
Revenue growth 5Y16.45%
Sales Q2Q%415.75%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AHG Yearly Revenue VS EstimatesAHG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 20M 40M 60M 80M 100M
AHG Yearly EPS VS EstimatesAHG Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for AHG. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AHG Price Earnings VS Forward Price EarningsAHG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, AHG is valued a bit more expensive than 62.38% of the companies in the same industry.
Industry RankSector Rank
P/FCF 703.48
EV/EBITDA N/A
AHG Per share dataAHG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • AHG does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AKSO HEALTH GROUP

NASDAQ:AHG (3/2/2026, 8:01:44 PM)

1.31

-0.11 (-8.07%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)12-04
Earnings (Next)N/A
Inst Owners0.03%
Inst Owner Change10.8%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap719.45M
Revenue(TTM)14.78M
Net Income(TTM)-134.98M
AnalystsN/A
Price TargetN/A
Short Float %0.01%
Short Ratio1.14
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 48.68
P/FCF 703.48
P/OCF 611.16
P/B 3.61
P/tB 3.99
EV/EBITDA N/A
EPS(TTM)-0.29
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFY0.14%
OCF(TTM)0
OCFY0.16%
SpS0.03
BVpS0.36
TBVpS0.33
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -62.79%
ROE -67.79%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM 6.92%
ROA(3y)-25.43%
ROA(5y)-42.59%
ROE(3y)-30.24%
ROE(5y)-85.85%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 1.96
Debt/EBITDA N/A
Cap/Depr 7.19%
Cap/Sales 1.05%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 14.2
Quick Ratio 14.18
Altman-Z 29.39
F-Score4
WACC7.53%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-146.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-374.64%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)512.09%
Revenue growth 3Y35.05%
Revenue growth 5Y16.45%
Sales Q2Q%415.75%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y54.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-24.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-12.88%
OCF growth 3YN/A
OCF growth 5YN/A

AKSO HEALTH GROUP / AHG FAQ

What is the fundamental rating for AHG stock?

ChartMill assigns a fundamental rating of 3 / 10 to AHG.


Can you provide the valuation status for AKSO HEALTH GROUP?

ChartMill assigns a valuation rating of 0 / 10 to AKSO HEALTH GROUP (AHG). This can be considered as Overvalued.


Can you provide the profitability details for AKSO HEALTH GROUP?

AKSO HEALTH GROUP (AHG) has a profitability rating of 1 / 10.